<i>Zuojin</i> Pill inhibits the proliferation of esophageal cancer cells by inducing ROS production and apoptosis via regulation of PI3K/Akt signalling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Zuojin Pill inhibits the proliferation of esophageal cancer cells by inducing ROS production and apoptosis via regulation of PI3K/Akt signalling

Published:2024-06-14 Issue:1 Volume:18 Page:
ISSN:1658-3655
Container-title:Journal of Taibah University for Science
language:en
Short-container-title:Journal of Taibah University for Science

Author:

Wang Lingyu¹,Li Ruolan¹,Li Meiyan¹,Sun Jiayi¹,Liu Jia¹,Xie Min²,Chen Yunhui¹,Tang Songqi³

Affiliation:

1. School of Pharmacy/School of Basic Medical Sciences/CDUTCM-KEELE Joint Health and Medical Sciences Institute/Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China

2. West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, People’s Republic of China

3. School of Chinese Medicine, Hainan Medical University, Haikou, People’s Republic of China

Funder

International Cooperation and Exchange Project of Science & Technology Department of Sichuan Province

Sichuan Provincial Administration of Traditional Chinese Medicine

National Natural Science Foundation of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/16583655.2024.2361991

Reference33 articles.

1. Esophageal cancer;Short MW;Am Fam Physician,2017

2. Recent progress in multidisciplinary treatment for patients with esophageal cancer

3. Cancer statistics, 2022

4. Treatments for esophageal cancer: a review

5. Radiation-induced skin injury: pathogenesis, treatment, and management

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP